Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer
4
×
clinical trials
life sciences
national blog main
san francisco blog main
4
×
cancer drugs
national top stories
san francisco top stories
eli lilly
european society for medical oncology
fda
investing
ipo
mirati therapeutics
revolution medicines
san francisco
sanofi
the column group
third rock ventures
warp drive bio
89bio
abbvie
adrian krainer
alexion pharmaceuticals
alzheimer europe conference
alzheimer's disease
amgen
astrazeneca
bain capital
biogen
biotech ipos
black diamond therapeutics
bladder cancer
blueprint medicines
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
What
research
4
×
cancer
drug
ipo
medicines
biotech
proteins
revolution
targets
alzheimer’s
annual
assessed
attention
bio
black
cancer’s
clinic
communities
companies
conference
despite
diamond
disease
eluded
esmo
europe
family
frontiers
germany
hardest
hit
hopes
hosted
hottest
hunters
investment
known
lead
leading
lines
Language
unset
Current search:
research
×
cancer
×
" san francisco blog main "
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
